The QualityStocks Daily Wednesday, September 11th, 2019

Today's Top 3 Investment Newsletters

StockMarketWatch (TTOO) +82.52%

QualityStocks (IDNG) +81.48%

PoliticsAndMyPortfolio (FRAN) +59.42%

The QualityStocks Daily Stock List

Interlink Electronics, Inc. (LINK)

Stock Twits, Investing.com, Street Insider, MacroTrends, BusinessWire, Capital Cube, Stockopedia, AI Stock Finder, GlobeNewswire, Last10k, Simply Wall St, Stockhouse, Market Screener, 4-Traders, Morningstar, TMXmoney, and InvestorsHub reported previously on Interlink Electronics, Inc. (LINK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Interlink Electronics, Inc. is a world-leading trusted advisor and technology partner in the advancing world of human-machine interface (HMI) and force-sensing technologies. The Company has led the printed electronics industry in its commercialization of its patented Force-Sensing Resistor (FSR®) technology that has enabled rugged and reliable HMI solutions. Interlink delivers multi-platform sensor solutions to the world's major OEMs (original equipment manufacturers), Tiers and Integrators.

Established in 1985, Interlink Electronics is headquartered in Camarillo, California. The Company also has its worldwide research and development center in Singapore, its printed-electronics manufacturing facility in Shenzhen, China, and its worldwide distribution and logistics center in Hong Kong. In addition, Interlink maintains technical and sales offices in Japan and at various locations in the U.S.

The Company has a proven record of accomplishment supplying HMI solutions for mission-critical applications in a broad array of markets. This includes, but is not limited to, consumer electronics, automotive, industrial, as well as medical devices. Its solutions have centered on handheld user input, menu navigation, cursor control, and other intuitive interface technologies for the world's leading electronics manufacturers.

Interlink Electronics’ product development teams skilled capabilities are in concept definition, rapid prototyping, hardware and firmware development, and integration support. The Company’s standard products include Force Sensing Resistor® technology; force sensing linear potentiometers (FSLP) – position sensing; and integrated mouse modules & pointing solutions. Nonetheless, the largest part of the Company’s business today is the development and manufacture of custom products (custom solutions) for some of its major customers.

Interlink Electronics serves Fortune 500 companies, start-ups, design houses, original design manufacturers, OEMs, and universities in diverse markets, including consumer electronics, automotive, industrial, and medical. The Company does so via direct sales employees, and also outside sales representatives and distributors. As Interlink Electronics transitions from an FSR® sensor supplier to an HMI solution provider, it is pursuing and embracing leading-edge sensor technology platforms.

Interlink Electronics, Inc. (LINK), closed Wednesday's trading session at $3.50, up 12.9032%, on 2,937 volume with 11 trades. The average volume for the last 3 months is 430 and the stock's 52-week low/high is $1.62/$5.34959983.

chart

AMP Limited (AMLTF)

Stock Scores, TeleTrader, TipRanks, Invest Tribune, PR Newswire, Dividend Investor, 4-Traders, Market Screener, Investing.com, Stockhouse, Morningstar, Stockwatch, TradingView, ad Wallet Investor reported previously on AMP Limited (AMLTF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

AMP Limited operates as a wealth management company in Australia and globally. It operates by way of the Australian Wealth Management, AMP Capital, AMP Bank, and New Zealand Wealth Management segments. AMP offers solutions and services across financial advice, investment management, banking, superannuation, self-managed superannuation funds (SMSFs), life insurance, retirement income and investing.

The Company lists on the OTC Markets. AMP Limited has its corporate headquarters in Sydney, Australia. The Company began in 1849 as the Australian Mutual Provident Society, offering life insurance. AMP has developed over 170 years to be a publicly listed, international wealth manager. AMP’s reach now spans around the world, where the Company uses its expertise to advise clients and customers in Asia, the Middle East, Europe, the United Kingdom (UK) and North America.

In 2009, AMP and China Life Group formed a strategic partnership. In 2011, AMP and AXA Asia Pacific merged and AMP and Mitsubishi UFJ Trust and Banking formed a strategic partnership. In 2017, AMP Capital takes a minority stake in U.S. based real estate investment manager PCCP.

Australian Wealth Management help its customers to save for, and to live well in retirement, with its retail and workplace superannuation products, self-managed superannuation funds services, and retirement income solutions and investments for individuals. AMP Bank provides customers with residential and investment property home loans, deposit and transaction accounts and SMSF products. AMP Bank also provides loans to AMP-aligned financial advice practices.

AMP Capital manages investments in equities, fixed income, diversified, multi-manager and multi-asset funds on behalf of clients worldwide. In 2018, AMP Capital managed real estate and infrastructure assets including shopping centers, airports, trains and pipelines, with $20.3 billion in infrastructure investments managed on behalf of funds and clients. New Zealand Wealth Management provides customers in New Zealand with financial products and services, directly and through one of the largest networks of financial advisers in the country.

Last month, AMP announced an agreement to sell its Australian and New Zealand wealth protection and mature businesses to Resolution Life, with a completion date in the first half of 2020.

AMP Limited (AMLTF), closed Wednesday's trading session at $1.23, up 14.9533%, on 8,610 volume with 2 trades. The average volume for the last 3 months is 4,874 and the stock's 52-week low/high is $1.07000005/$2.44000005.

chart

Better Choice Company, Inc. (BTTR)

Street Insider, Market Screener, GlobeNewswire, All Cap Research, TeleTrader, Stockwatch, TradingView, Simply Wall St, Wallet Investor, InvestorsHub, and Stockhouse reported previously on Better Choice Company, Inc. (BTTR), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Better Choice Company, Inc. is an animal health and wellness CBD (cannabidiol) company based in New York City. It has acquired TruPet LLC and Bona Vida, Inc. Better Choice Company offers consumers a carefully curated collection of premium pet brands, hemp-derived CBD supplements, and other services that support pet wellness. The Company lists on the OTC Markets Group’s OTCQB.

Better Choice’s vision is to provide clean, holistic, and nutritional options for consumers who want to bring their own healthier lifestyle to their pets. The Company’s products promote wellness and support better and longer lives for pets.

Better Choice’s TruPet is an online seller of ultra-premium, all-natural pet food, treats and supplements. TruPet has a special emphasis on freeze dried and dehydrated raw products. Bona Vida is an inventive emerging CBD platform. Bona Vida’s emphasis is on developing a portfolio of brand and product verticals within the animal and human health and wellness space.

Better Choice’s portfolio includes TruDog, an online seller of ultra-premium, freeze-dried raw pet food, treats and supplements, and Elvis Presley’s Hound Dog, a unique CBD platform. Furthermore, the Company’s portfolio includes TruGold, a hemp-based product line, and Rawgo!, a premium dehydrated dog food. In addition, its portfolio includes Orapup, a dental health system for dogs, TruCat, a premium pet food and supplements brand for cats, and Pet Premium, a leading pet insurance provider.

Better Choice announced this past June a strategic partnership with Authentic Brands Group (ABG). ABG (New York, New York) is a global brand development, marketing and entertainment company and owner of Elvis Presley Enterprises LLC. The strategic partnership is to launch an all-new line of CBD pet products under the Elvis Presley Hound Dog brand.

In August, Better Choice announced that it entered into a research partnership with Green Element BV, a Dutch research firm, to conduct clinical research in the Netherlands on the anxiety reduction potential of Better Choice CBD canine products. The aim of the clinical study is to measure the efficacy of CBD dog products in lessening anxiety symptoms among canines diagnosed with separation and social anxiety. The expectation is that the clinical study will begin during Q4 of 2019 and last between six to eight months, at which time the data will undergo evaluation.

Also in August, Better Choice and ABG announced the launch of a CBD pet product line under the Elvis Presley Hound Dog brand, with an initial release of two SKUs (Stock Keeping Units), Hound Dog Peanut Butter Calming & Relaxation Support Supplement, and Hound Dog Bacon Skin & Immune Support Supplement.

Damian Dalla-Longa, Co-Chief Executive Officer of Better Choice Company, said, “We are constantly striving to put out the highest quality products for pet parents, and with ABG, we have developed a product to help dogs live their best lives. We believe that good health practices and nutrition contribute to and promote a higher quality of life for our pets.”

Better Choice Company, Inc. (BTTR), closed Wednesday's trading session at $3.63, up 0.833333%, on 302 volume with 3 trades. The average volume for the last 3 months is 8,054 and the stock's 52-week low/high is $1.32599997/$13.2600002.

chart

eMARINE Global, Inc. (EMRN)

TipRanks, StockPulse, TeleTrader, Global Banking and Finance, Wallmine, Market Wire News, Street Insider, Wallet Investor, Stockhouse, Market Screener, InvestorsHub, Morningstar, Stockopedia, Nasdaq, GlobeNewswire, Stockwatch, Simply Wall St, and TradingView reported earlier on eMARINE Global, Inc. (EMRN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

eMARINE Global, Inc. is a foremost provider of information and communications technology (ICT) for the maritime industry. It provides solutions for the collection, integration and display of maritime information abroad and ashore via electronic means to enhance berth to berth navigation and related services. The Company previously went by the name Pollex, Inc. It changed its name to eMarine Global, Inc. in August of 2017. Incorporated in 2001, eMARINE Global has offices in Ulsan and Seoul, South Korea.

The Company is working with an increasing base of marquee customers to attain maritime ICT convergence via fully integrated products and services. It offers state-of-the-art e-navigation, marine Internet of Things (IoT), and marine big data solutions, chiefly in Korea with near-term expansion into U.S. and Chinese markets.

The Company’s solutions provide the most efficient means to secure the safety of life at sea and to protect the marine environment. All products and services are offered through subscription, installation, updates and/or maintenance contracts.

eMARINE Global offers electronic chart display and information systems (ECDIS), a computer-based navigation system; and electronic navigation charts (ENC), which integrates position information from the global positioning system (GPS) and other navigational sensors, including radar, fathometer, and automatic identification systems.

In addition, the Company provides smart ship solutions, including intra-ship integrated gateway (ISIG), an intra-ship network; collision avoidance and optimal voyage systems; and remote maintenance and engine monitoring systems. eMARINE Global engages in the distribution of overseas solutions, such as CARIS, a maritime GIS software; digital charts; and Hatteland, a maritime-specialized hardware. Furthermore, the Company provides Aids to Navigation (AtoN) management systems comprising maritime weather signals total management system, and e-A2N device.

This past July, eMARINE Global announced that it signed a contract with Ulsan IT Industry Promotion Agency (UIPA) to develop a full mission ship bridge simulator for the National Autonomous Ships’ Test Bed in Ulsan. This contract is valued at an estimated 650 million won (US$0.5 million). The simulator is used to test the autonomous ships before sea-trial, to simulate their operation and traffic control in a virtual environment, and to acquire data from marine equipment for more testing and development.

Recently, eMARINE Global announced that it signed a contract with the Republic of Korea Navy for the maintenance of its Anti-Submarine Warfare Team Trainer (ASWTT) at the Jin-Hae Naval Base. The contract is valued at an estimated 920 million won (US$0.76 million). Since 2017, eMARINE Global has maintained the ASWTT virtual reality simulator, used to simulate battles between warships and submarines. The simulator technology was developed by Sindel, an Italian technology company.

eMARINE Global, Inc. (EMRN), closed Wednesday's trading session at $1.00, up 42.8571%, on 202 volume with 1 trade. The average volume for the last 3 months is 1,785 and the stock's 52-week low/high is $0.349999994/$4.00.

chart

Excellon Resources, Inc. (EXLLF)

Resource World, InvestorX, Northern Miner, Geology for Investors, Trading View, InvestorsHub, Proactive Investors, StreetWise Reports, HotStocked, Proactive Investors, Stockwatch, Stockhouse, and Wallet Investor reported earlier on Excellon Resources, Inc. (EXLLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Excellon Resources, Inc. is a silver mining and exploration company based in Toronto, Ontario. Its 100 percent-owned Platosa Mine has been Mexico's highest-grade silver mine since production began in 2005. In 1996, Excellon was introduced to the La Platosa Project by Dr. Peter Megaw. Excellon Resources lists on the OTC Markets.

The Company is focusing on optimizing Platosa's cost and production profile and discovering further high-grade silver and carbonate replacement deposit (CRD) mineralization on the Platosa Project. The Platosa Mine is in a safe jurisdiction with grid power and the national highway runs through the property. It is 5km north of Bermejillo, Durango State, Mexico and is 20,969 hectares.

In addition, Excellon is focusing on epithermal silver mineralization on the 100 percent-owned 45,000 hectare Evolution Property. The Evolution Property is in Miguel Auza, Zacatecas, Mexico. It is situated 220 km from the La Platosa Mine. There is a new exploration prospect on the underexplored northern strike of the legendary Fresnillo silver trend, the most prolific silver belt in the world. Moreover, Excellon Resources is focusing on capitalizing on current market conditions through acquiring undervalued projects in the Americas.

At the beginning of August, Excellon Resources reported financial results for the three- and six-month periods ended June 30, 2019. The Company had strong revenue of $8.7 million despite lower metal prices (Q2 2018 – $9.9 million ). It had Silver equivalent (AgEq) production of 582,937 ounces (Q2 2018 – 637,205 AgEq ounces). Excellon also had AgEq ounces payable sold of 660,292 (Q2 2018 – 568,370 AgEq ounces payable). Mined tonnage was 30 percent higher in H1 2019 in comparison to H2 2018.

Recently, Excellon Resources announced that it closed its earlier announced bought deal public offering of 10,925,000 units, including 1,425,000 Units issued upon full exercise of the over-allotment option, at a price of $1.06 per Unit for aggregate gross proceeds of roughly $11.5 million. Its intention is to use the net proceeds of the Offering to fund exploration and capital expenditures at its Platosa Project in Durango, Mexico and Evolution Property in Zacatecas, Mexico , for corporate development and for general corporate purposes.

Excellon Resources, Inc. (EXLLF), closed Wednesday's trading session at $0.81, up 3.9795%, on 80,528 volume with 72 trades. The average volume for the last 3 months is 92,885 and the stock's 52-week low/high is $0.442999988/$1.14999997.

chart

Manganese X Energy Corp. (SNCGF)

Ahead of the Herd, Bull Market News, Market Screener, Geology for Investors, Investing News, InvestorIntel, Oil & Gas 360, 4-Traders, The Prospector, Mining Stock Education, StreetWise Reports, Stockwatch, Wallet Investor, and Stockhouse reported beforehand on Manganese X Energy Corp. (SNCGF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Manganese X Energy Corp.’s mission is to acquire and advance high potential manganese mining prospects in North America. The Company’s intention is to supply value added materials to the lithium ion battery and other alternative energy industries. Manganese dioxide is a key element in the manufacture of the most promising types of Lithium Ion batteries. These types of batteries are the most promising because of their superior storage capacity, safety, and cost.

The Company formerly went by the name Sunset Cove Mining, Inc. It changed its name to Manganese X Energy Corp. in December 2016. Manganese X Energy has its head office in Saint-Laurent, Quebec.

Manganese X Energy has created a standalone subsidiary within the parent Company named Disruptive Battery Corp. It has secured the domain batterydisruptors.com. The new company was created to hasten a manganese thesis as it relates to fuel cells and stored energy. The intention is to advance the movement of manganese for greener power production and penetrating the EV (Electric Vehicle) market.

Manganese X Energy’s plan is to provide a secure ethically sourced manganese supply by exploring and developing its manganese rich deposit near Woodstock, New Brunswick (Battery Hill Project). The Battery Hill property consists of 55 claims totaling 1,228 hectares situated in Carlton County, New Brunswick. The project covers all or part of five manganese zones - Iron Ore Hill, Moody Hill, Sharpe Farm, Wakefield and Maple Hill.

Additionally, Manganese X Energy has its Peter Lake Property. Peter Lake consists of 34 claims totalling roughly 1985 Ha located in the Mont-Laurier Terrane, in the Central Grenville Province, Quebec. Two Copper-Nickel-Cobalt Occurrences called Peter Lake North and Peter Lake South are included within the Property. Previous grab sampling returned values ranging from 0.4 percent to 22.8 percent copper, 0.14 percent to 0.73 percent nickel, 500 ppm to 0.266 percent cobalt, as well as elevated gold and silver.

The Peter Lake Property, about 20 kms south of Kintavar Exploration, Inc.'s Mitchi Project, is where Kintavar announced significant new copper, silver, and gold mineralization (Kintavar News Release dated August 8, 2018). Manganese X Energy plans to conduct an exploration program on Peter Lake, with a complete compilation of historic geological work, followed by line cutting, ground geophysics, geology/prospecting, trenching and possible diamond drilling in the future. Special attention during the exploration program will be targeted at the cobalt and possible gold-platinum-palladium potential of the Property.

Last week, Manganese X Energy announced ongoing collaboration with Kemetco Research, Inc. by a contract signed to continue to develop and enhance its ultra-high purity material from its previous metallurgical project (March 2019). The previous project was able to produce manganese sulfate with a purity exceeding 99.6% and low levels of base and alkali metals using material from the Battery Hill property that consists of rhodochrosite, a manganese carbonate mineral. Manganese X Energy's preliminary flow sheet used specific parameters for Battery Hill ore and yielded very encouraging results. The flow sheet incorporated leaching followed by solid-liquid separation, purification and crystallization.

Manganese X Energy, together with Kemetco, will now continue to develop a commercializable flow sheet to produce ultra-high-purity (>99.9%) battery-grade manganese product for the growing electric vehicle and energy storage sectors, using the safe and sustainable North America mineralization at Battery Hill. The estimated project time frame will be 10-12 weeks.

Manganese X Energy Corp. (SNCGF), closed Wednesday's trading session at $0.0707, even for the day, on 8,888 volume. The average volume for the last 3 months is 370 and the stock's 52-week low/high is $0.065949998/$0.155599996.

chart

Repro Med Systems, Inc. (REPR)

Zacks, Streetwise Reports, Market Screener, Wallmine, InvestorsHub, Wallet Investor, Business Wire, Equity Clock, Dividend Investor, Simply Wall St, Infront Analytics, Stockwatch, Capital Cube, and Stockhouse reported beforehand on Repro Med Systems, Inc. (REPR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Repro Med Systems, Inc. does business as RMS Medical Products (REPR) (RMS Medical). RMS Medical develops, manufactures and commercializes inventive and user-friendly specialty infusion solutions that improve quality of life for patients worldwide. The Company has its FREEDOM Syringe Infusion System. OTCQX-listed, Repro Med Systems has its corporate office in Chester, New York.

Currently, the FREEDOM Syringe Infusion System includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. Repro Med Systems sells its products through direct sales and medical device distributors, as well as online.

In April 2019, Repro Med Systems announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its HIgh-Flo Super26™ Subcutaneous Needle Sets (Super 26 Needle Sets). The Super26 Needle Sets are indicated for subcutaneous infusion of medications in the home, hospital, or ambulatory settings to facilitate high flow rates. This includes human plasma-derived immunoglobulins such as Hizentra® and Cuvitru™.

Recently, Repro Med Systems, Inc. dba RMS Medical Products announced financial results for Q2 2019 ended June 30, 2019. Selected Q2 highlights include Net Sales increasing 18.8 percent to $5.3 million. In addition, the Company’s Gross Margin improved to 65.0 percent. Net Income for Q2 2019 was $0.1 million versus Net Income of $0.5 million in Q2 2018. The variance was mainly because of an increase in expenses in Q2 2019.

Q2 2019 Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to $1.5 million, or 27.9 percent of Net Sales, from Adjusted EBITDA of $0.9 million, or 20.7 percent of Net Sales, in Q2 2018. Repro Med Systems ended the quarter with $3.8 million in cash and no debt. Moreover, the Company further strengthened its management and Board of Directors in Q2 2019.

Repro Med Systems, Inc. (REPR), closed Wednesday's trading session at $4.00, even for the day, on 20,294 volume with 37 trades. The average volume for the last 3 months is 56,578 and the stock's 52-week low/high is $1.35000002/$4.25990009.

chart

Blue Eagle Lithium, Inc. (BEAG)

All Penny Stocks, Simply Wall St, Nasdaq, Financial Buzz, Stockhouse, OTC Markets, Last10k, and Market Screener reported earlier on Blue Eagle Lithium, Inc. (BEAG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A lithium exploration company, Blue Eagle Lithium, Inc. engages in identifying, evaluating, and developing early-stage lithium exploration opportunities in North America. The design of the Company’s growth strategy is to maximize shareholder value through a singular emphasis on lithium exploration and development in secure and stable North American regions. OTCQB-listed, Blue Eagle Lithium has its corporate headquarters in Henderson, Nevada.

The Company’s initial property is in Railroad Valley, Nevada, a highly prospective green-fields Petro-Lithium brine target region that features numerous similarities to the nearby Clayton Valley and which Blue Eagle Lithium believes warrants an extensive exploration program. It has a 100 percent Working Interest (WI) in 276 placer claims in Railroad Valley.

The Company’s Railroad Property warrants surface and shallow drilling evaluation for possible surface-mineable lithium-rich units based on different sources of geological data. The main exploration target within the Railroad Property would be more recent playa sediments, mostly within 2,000 feet (610 meters) of the valley’s surface. Railroad Valley is an isolated sedimentary basin. It exhibits all the important attributes of a large commercial petro-lithium discovery.

Recently, Blue Eagle Lithium announced that it has engaged Rangefront Geological to begin an extended soil sampling program covering its original 4,000 acre land position in Railroad Valley and its recently acquired acreage, the latter of which has received only limited evaluations to date. Rangefront Geological is a premier geological contracting and consulting company based locally out of Elko, Nevada. A crew from Rangefront will be mobilized to start work on the properties with the goal to gather up to 250 near surface clay and brine samples.

In addition, Blue Eagle Lithium announced it further extended its land package through the exercise of an option agreement clause. This extends its land holdings by an additional 520 acres (26 Mineral Claims). In total, the land package now held by Blue Eagle Lithium is 5,520 acres (276 claims, approximately 2,223 Hectares).

Blue Eagle Lithium, Inc. (BEAG), closed Wednesday's trading session at $0.32, up 23.0769%, on 24,788 volume with 15 trades. The average volume for the last 3 months is 695,571 and the stock's 52-week low/high is $0.449999988/$3.50.

chart

NanoFlex Power Corp. (OPVS)

Dividend Investor, Zacks, Wallet Investor, Stockhouse, MarketWatch, MicroCapResearch, InvestorsHub, Super Stock Screener, and Morningstar reported earlier on NanoFlex Power Corp. (OPVS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

NanoFlex Power Corp. engages in the research, development, and commercialization of advanced configuration solar technologies. These technologies enable innovative thin-film solar cell implementations. The Company believes these will be industry-leading efficiencies, light weight, flexible, and low total system cost. Listed on the OTC Markets Group’s OTCQB, NanoFlex Power has its corporate office in Scottsdale, Arizona.

The Company’s sponsored research agreements provide it with the exclusive worldwide license and right to sublicense any and all Intellectual Property (IP)  resulting from the related research and development (R&D) efforts at different universities. NanoFlex Power entered into a license agreement with SolAero Technologies Corp. For the last two-plus years, the Company and SolAero have partnered to validate NanoFlex's patented, non-destructive epitaxial lift-off (ND-ELO) process and related technologies in SolAero's ultra-high efficiency solar cells.

SolAero is a global leader in high performance photovoltaics for space and terrestrial applications. SolAero is a leading manufacturer of high efficiency solar cells.

NanoFlex Power is part of a consortium that was awarded a $6.5 million contract from the Army Research Laboratory's Army Research Office. This consortium comprises NanoFlex Power,  SolAero Technologies, the University of Michigan (UM), and the University of Wisconsin (UW).   The contract is to develop high power, flexible, and lightweight solar modules for portable power applications with more than double the power of existing flexible solar modules within the same footprint at a competitive procurement cost on a dollars per Watt basis.

Research programs have produced two solar thin film technology platforms. One is Gallium Arsenide (GaAs) thin film technology for high power applications. The other is organic photovoltaic (OPV) technology for applications requiring high quality aesthetics.

NanoFlex Power has the exclusive worldwide rights to license, sublicense, and bring its own products to market using the aforementioned  ND-ELO technology. ND-ELO technology has the potential to reduce compound semiconductor production costs by greater than 40 percent through enabling reuse of the expensive wafer substrate.

NanoFlex Power Corp. (OPVS), closed Wednesday's trading session at $0.144, up 33.9535%, on 1,500 volume with 2 trades. The average volume for the last 3 months is 9,064 and the stock's 52-week low/high is $0.041000001/$0.31915.

chart

Advanced BioMedical Technologies, Inc. (ABMT)

Zacks, Stockrow, and 4-Traders reported on Advanced BioMedical Technologies, Inc. (ABMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Advanced BioMedical Technologies, Inc. manufactures and distributes advanced impedance controlled micro-current instruments.  The Company has treated more than 15,000 patients during the past 28 years. It is a leader in education, research, training, and instrument sales and works with doctors and clinicians throughout the U.S. This includes those in Minnesota, the majority of which have an affiliation with the University of Minnesota. Advanced BioMedical Technologies is based in Eagan,  Minnesota.

The Company is the oldest distributor of the Electro-Acuscope and Electro-Myopulse. Advanced BioMedical has a 6,000-square foot office complex, with 3,000 square feet dedicated as a patient care treatment center.

The Electro-Acuscope and Electro-Myopulse instruments feature the most sophisticated computerized, feedback-controlled, energy delivery, micro-current technology available today. Acuscope products include the Electro-Acuscope 85P (Portable); the Electro-Acuscope 80L; and the Neuroscope 230B. Myopulse products include the Electro-Myopulse 75L (Base Model) and the Electro-Myopulse 75F (used in Fermi Lab Study).

The Electro-Myopulse measures the Bio-Impedance of the muscle tissue between the two electrodes. Similarly, this is how the current amplitude and voltage output is adjusted and controlled. The Myopulse uses a sine wave. This sine wave imitates the wave produced when a muscle first contracts.

The Electro-Acuscope monitors nerve conduction between two electrodes. This is how the current amplitude and voltage output is adjusted and controlled. The Acuscope uses a complex waveform. This waveform imitates a nerve impulse.

The Neuroscope 230B (Home Care Unit) is for the personal treatment of sleep, anxiety,  and pain issues. The product is a personal treatment device for the person on the go. Moreover, it is as an adjunct to Acuscope and Myopulse (impedance controlled microcurrent) therapy where extended rehabilitation therapy  require  more treatments at home.  

The design of the Electro-Acuscope 85P (Portable)  instrument is for the traveling clinician or patient (with prescription). This instrument is built into a haliburtor case for safe and easy portability.

Furthermore, Advanced BioMedical Technologies has its La Fleur products. These include the Electro-Myopulse 75LN Premium Instrument (Myopulse, Facial and Esthetics), which was developed exclusively by the Company. In addition, the Company carries a line of Accessories.

Recently, Advanced Biomedical Technologies announced that the State Intellectual Property Office of The People’s Republic of China (SIPO) issued the Company a new patent titled “Bone Fracture Plate Made of High Polymer Materials”.

Its subsidiary Shenzhen Changhua Biomedical Engineering Company Limited is entitled for the new patent (ZL 2014 1 0647464.1), which strengthens the Company's position in manufacturing process and related controls using its innovative polyamide materials (PA).

Advanced BioMedical Technologies, Inc. (ABMT), closed Wednesday's trading session at $0.189, up 26.00%, on 763 volume with 3 trades. The average volume for the last 3 months is 295 and the stock's 52-week low/high is $0.07/$0.75.

chart

KinerjaPay Corp. (KPAY)

OTC Markets, InvestorsHub, MarketWatch, TradingView, Stockhouse, Marketbeat, and Barchart  reported on KinerjaPay Corp. (KPAY), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Established in 2010, KinerjaPay Corp. focuses on operating  a  digital payment and  e-commerce platform.  The  Company,  through  its wholly-owned subsidiary,  PT Kinerja Pay Indonesia, enables consumers to "pay, play,  and buy"  via  its secure website and mobile applications.  KinerjaPay’s intention is to establish the Company as a leader in Indonesia's digital economy, with a specific emphasis on the middle- and low-income markets.  KinerjaPay  is based in Indonesia.

A digital payment and ecommerce platform,  KinjerPay’s  services are available through its mobile applications,  and  on its website at www.kinerjapay.com.  The  KinerjaPay platform provides a secure payment solution.  In addition, it  provides  a developing  virtual marketplace  where participants can buy and sell products and services.

In May 2016, KinerjaPay entered into a partnership with Bitcoin Indonesia. This makes KinerjaPay the first e-commerce portal in Indonesia authorized to accept and transact Bitcoin  across its platform. This  enables  account holders to convert the virtual currency to Indonesian Rupiah to pay their bills, transfer money, or make purchases in the Company's ecommerce market.

KinerjaPay  offers several  in-app services that cater  to mobile users. These in-app services include  an eWallet, social engagement, and digital entertainment related applications. Additionally,  the Company is  pursuing other e-commerce verticals. These include travel, fashion, gaming, and  productivity applications.

Moreover, KinerjaPay  has  created  a number of unique  features designed to engage users. This includes  an  interactive gamification component that  permits  users to play and earn rewards while enjoying the benefits of shopping online. The Company is also  providing users the convenience of making online payments of their utility bills, phone top-ups/data plans, insurance premiums, automobile loan instalments, and many  other  applications.

KinerjaPay plans to expand its digital ecommerce platform with the launch of KinerjaGames. It entered a long-term License Agreement with Ace Legends Pte. Ltd. (ACE). ACE is a  Singapore-based game developer.

With this Agreement, in exchange for a $100,000 investment, KinerjaPay will become the exclusive, worldwide Game Publisher License for ACE games. The Company will also host all the games now published by ACE on its own KinerjaGames platform.

Recently, KinerjaPay announced its partnership with Uber Technologies, Inc. Uber is the worldwide smartphone-enabled 'Ride-Hailing' service.

With this partnership, Uber will grant KinerjaPay users an exclusive promotion code for first-time users, valid for four rides. Users can at first redeem the Uber/KinerjaPay promotion code by creating a new account on the Company's eCommerce platform or meeting a certain spending threshold with KinerjaPay's proprietary KinerjaMall service. User/clients can subsequently redeem their unique code directly in their KinerjaPay smartphone app to use the Uber service.

KinerjaPay also recently announced that it has chosen Blockchain Industries, Inc. and Fintech Global Consultants to transition to a token payment platform. Blockchain Industries, in partnership with Fintech Global Consultants, will be guiding KinerjaPay in its transition from an electronic payment platform to a token payment platform.

KinerjaPay’s plan is to raise up to US $5 million from its imminent ICO (initial coin offerings). The ICO will be offered to institutional or private investors in the form of KCOIN, KinerjaPay's own proprietary virtual currency. With the ICO, KCOIN will be used as KinerjaPay's cryptocurrency on one of the largest cryptocurrency exchanges in Asia.

KinerjaPay Corp. (KPAY), closed Wednesday's trading session at $0.162, up 29.6%, on 964,460 volume with 119 trades. The average volume for the last 3 months is 685,906 and the stock's 52-week low/high is $0.090000003/$0.949899971.

chart

Dais Analytic Corp. (DLYT)

HotOTC, SmallCapVoice, CoolPennyStocks, MadPennyStocks, StockEgg, StockRich, Stockpalooza, Money Morning, Penny Stock Rumble, FeedBlitz, M2 Communications, SmallCap Pulse, BullRally,  PennyInvest, PennyStockVille, and Greenbackers  reported  earlier on Dais Analytic Corp. (DLYT), and today we are highlighting the Company , here at the QualityStocks Daily Newsletter.

Dais Analytic Corp sells its industry-changing nanomaterial technology into the global water, air, and energy markets. A commercial nanotechnology materials enterprise, the Company provides nanotechnology-based applications for heating & cooling, water treatment, and energy storage. It is commercializing its unique Aqualyte™ family of nano-structured materials and processes centering on disruptive air, energy, and water applications. Dais Analytic is headquartered in Odessa, Florida.  

The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™. This is a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product). 

In addition, the uses include NanoAir™. This is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle.  Uses also include NanoClear™. This is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water.

The NanoClear™ process has consistently shown that Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, realizing almost 'parts per billion' clean product water with little or no fouling of the vital membrane component. 

NanoClear™ is a leading-edege water cleaning architecture enabled by the features in the Company’s nanomaterial - Aqualyte™. The NanoClear™ product line is a critical application in purifying contaminated water having high salt content, low pH, or where the requirement for Total Dissolved Solid (TDS) in the product water is 10 or less. 

Furthermore uses include NanoCAP™. Dais indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive, non-chemical, energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, and also 'smart grid' configurations.

Recently, Dais Analytic announced it signed a 7 year, non-exclusive agreement with the Menred Group, Zhejiang province, China, to provide its Aqualyte moisture transfer nanomaterial for use in a newer line of Menred energy recovery ventilators (ERV) to sell into the increasing Chinese heating, ventilation and air conditioning (HVAC) market.

Energy Recovery Ventilators are used in association with HVAC equipment to save capital and operating costs. This is while improving the quality of life for the building's occupants.

High effectiveness ERVs, such as ConsERV™ or Menred Group's new line of ERVs to be built utilizing Dais Analytic's Aqualyte nanomaterial, enable architects and engineers to design buildings with considerable volumes of filtered, preconditioned supply air.

Mr. Brian Johnson Dais Analytic’s Chief Technology Officer, said in July 2017, "Dais' ConsERV™ has long been a leader in this field as established by our Air-Conditioning, Heating and Refrigeration Institute (AHRI) certified performance -- along with other similar ratings from 3rd party rating company's worldwide. Our Aqualyte™ nanomaterial, now in its 4th generation, drives this performance and we are excited about working with Menred to bring a new series of ERVs with Aqualyte to the growing Chinese ERV market."

Dais Analytic Corp. (DLYT), closed Wednesday's trading session at $0.001, up 25.00%, on 9,453,867 volume with 49 trades. The average volume for the last 3 months is 16,551,086 and the stock's 52-week low/high is $0.000699999/$0.045899998.

chart

RedHawk Holdings Corp. (IDNG)

TopPennyStockMovers, Real Pennies, Greenbackers, Fast Money Alerts, Mad Money Picks, The Observer, Innovative Marketing, Penny Stock General, Stock Shock and Awe, PennyStocks24, and Hot Stock Profits reported earlier on RedHawk Holdings Corp. (IDNG), and we also report on the Company, here at the QualityStocks Daily Newsletter.

RedHawk Holdings Corp. is a diversified holding company listed on the OTC Markets. The Company, via its subsidiaries, engages in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. RedHawk Holdings was formerly Independence Energy Corp. RedHawk’s subsidiaries are RedHawk Medical, EcoGen Europe, RedHawk Energy Corp., and RedHawk Land & Hospitality. RedHawk Holdings is based in Louisiana.

RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System. This System is a unique, closed cabinet, nominal dose transmission full body x-ray scanner.

Through its RedHawk Medical Products business unit, RedHawk Holdings sells WoundClot Surgical - Advanced Bleeding Control; the Sharps and Needle Destruction Device (SANDD™); the Carotid Artery Digital Non-Contact Thermometer, and Zonis®.

RedHawk Medical Products UK Limited is a specialist medical device company. It delivers innovative product solutions to healthcare markets in the United Kingdom (UK), Europe and the Middle East.

EcoGen Europe’s dedication is to healthcare and the NHS. Its commitment is to securing savings across the drug budget in primary care. This is while providing innovation to drive patient care in the acute setting. Last month, RedHawk Holdings announced that it recently completed its financial and legal due diligence and upon execution of final agreements, it will increase its ownership interest in EcoGen Europe to 75 percent.

RedHawk’s financial services revenue is from brokerage services earned in association with debt placement services and investments in oil and gas exploration and production. The Company’s real estate leasing revenues come from varied commercial properties under long-term lease. Moreover, its real estate investment unit holds limited liability company interest in different commercial restoration projects in Hawaii.

EcoGen Europe has signed an exclusive agreement to license and supply a new non-patent infringing generic spray formulation of Sildenafil Citrate in the UK. EcoGen will market the new spray under the brand name Azulvig. EcoGen expects to start marketing Azulvig after receipt of final UK regulatory approval.

RedHawk Holdings has acquired a stake in Tigress Energy Partners. RedHawk agreed to acquire up to a 25 percent interest in Marlin USA Energy Partners, LLC, the minority owner of Tigress Energy Partners, LLC (TEP). The majority ownership of TEP is held by Tigress Holdings, LLC, a limited liability company majority-owned by Cynthia DiBartolo, Chief Executive Officer of Tigress Financial Partners LLC (TFP).

RedHawk Holdings has also completed the re-engineering of its Sharps and Needle Destruction Device (SANDD). It received pre-market clearance from the U.S. Food and Drug Administration (FDA) for the sale of SANDD in the U.S. RedHawk Medical Products acquired the tangible and intangible property rights to SANDD (formerly known as the Disintegrator™ Insulin Needle Destruction Unit) in December 2015.

Recently, RedHawk Holdings announced that its wholly-owned real estate subsidiary, RedHawk Land & Hospitality LLC, entered into new agreements for the lease of its two commercial properties in Lafayette, Louisiana. The Company said it entered into a new triple-net lease agreement with the Louisiana 3rd Circuit Court of Appeal to renew and extend the present lease term to December 31, 2022. The new lease agreement was effective August 1, 2017 and included certain rate increases.

RedHawk Holdings Corp. (IDNG), closed Wednesday's trading session at $0.0049, up 81.4815%, on 42,484,777 volume with 338 trades. The average volume for the last 3 months is 13,757,970 and the stock's 52-week low/high is $0.000799999/$0.004199999.

chart

Agritek Holdings, Inc. (AGTK)

CFN Media Group, Promotion Stock Secrets, PennyPro, SmallCapVoice, and Cannabis Financial Network News reported on Agritek Holdings, Inc. (AGTK), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Formed in 2010, Agritek Holdings, Inc. is a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis sector. The Company provides innovative technology and agricultural solutions for the medicinal and recreational cannabis industry. Currently, Agritek owns property in Colorado approved for cultivation, and manufacturing capabilities through California partnerships. It also owns a number of Hemp and cannabis brands for distribution including "Hemp Pops" and "California Premiums". Agritek Holdings is headquartered in Miami, Florida. The Company has a satellite office in San Juan, Puerto Rico.

Agritek does not directly grow, harvest, or distribute or sell cannabis or any substances that violate or contravene United States law or the Controlled Substances Act. It does not intend to do so in the future. The Company’s solution is an integrated platform designed for commercialization in three high-value segments of the global cannabis market – Real Estate, AGTK Brands/IP, and Infrastructure.

Agritek’s Colorado property is 80-Acres approved for cannabis cultivation or manufacturing facility in Pueblo, Colorado. Its Puerto Rico property is a 25,000-sq. ft. licensed cannabis cultivation and manufacturing facility. Agritek’s Canada property is a cannabis friendly "Bud & Breakfast" concept. It is one 1-hour from Quebec City. It is on 15-acres that includes nine guest rooms plus a separate detached grow facility.

Agritek’s brands are a premium positioned set of consumer brands for medical wellness and recreational use. Agritek owns a number of hemp and cannabis brands for distribution. These include MD Vapes, MicroDose Strips, and the above-mentioned "Hemp Pops" and "California Premiums."

Agritek Holdings announced this past April that it completed, and fully executed, a five-year operational and exclusive licensing agreement with a 25,000-sq. ft. and one of the largest approved cultivation facilities in San Juan, Puerto Rico. The Company will be the exclusive funding source, and supervise all infrastructure buildout, equipment lease/finance, security systems and personnel and provide access of experienced Colorado and California cultivation crews to ensure the facility meets all standard operating procedures as set forth by the Department of Health of Puerto Rico.

With the five-year operational contract and licensing agreement, Agritek will receive revenue in the form of property rent, licensing fees on all vaporizer and edible brands, equipment and lighting rental and financing fees along with equity interest in the property.

Agritek Holdings previously announced that it executed a land purchase agreement to purchase a "420 Style" resort and estate property about one hour outside of Quebec City, Quebec. This 15-acre estate comprises nine innovative guest suites and horse stables. It is within walking distance to a public golf course that the Company will have ownership in for guests staying at the resort. A separate structure will serve as a small grow facility run by patient employees and caretakers on the property that may be toured by guests of the facility.

Recently, Agritek Holdings announced that Phase One of construction is commencing this month at the 1919 Clinic's 25,000 square foot cultivation and manufacturing facility located in San Juan, Puerto Rico. Agritek will provide funding for the build out of the operation, extraction and all equipment, and cultivation experts under the Agritek team via its executed five-year Operations and Licensing Agreement with 1919 Clinic.

Agritek Holdings also recently announced its initial orders from its' state licensed manufacturer for its brand "MicroDose" Oral Strips or "MD Strips" for the medicinal market of California. First orders and samples are being sent to dispensaries and local delivery services in San Diego and Orange County this month. Agritek will provide the licensing and packaging to produce the exclusive line of 10 mg and 50 mg oral strips as a medicinal alternative for patients.

Agritek Holdings, Inc. (AGTK), closed Wednesday's trading session at $0.2496, up 18.8571%, on 30,014 volume with 28 trades. The average volume for the last 3 months is 27,601 and the stock's 52-week low/high is $0.150000005/$2.77999997.

chart

The QualityStocks Company Corner

Quest Patent Research Corp. (OTCQB: QPRC)

The QualityStocks Daily Newsletter would like to spotlight Quest Patent Research Corp. (OTCQB: QPRC).

Quest Patent Research Corp. (OTCQB: QPRC), an intellectual property (IP) asset management firm specializing in mature and emerging technologies, provides IP asset owners and stakeholders with a valued resource for protection, management and monetization of IP assets such as patents, trademarks, copyrights, novel inventions and trade secrets. Headquartered in New York City, Quest offers shareholders the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.

Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (https://www.qprc.com/portfolio). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.

Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.

Objectives

Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities. Quest seeks to bridge this gap, partnering with asset owners – such as inventors, businesses, corporations and law firms – to help them fully realize the value of IP assets through:

  • IP Valuation
  • Structured Licensing Programs
  • Patent Prosecution
  • Partial or Full Liquidity
  • Portfolio Evaluation
  • Portfolio Maintenance
  • Legal Advisory
  • Attorney/Investor Referral
  • Patent Acquisition/Liquidation

At Quest, each partnership is treated as its own entity, with its own focused management comprised of Quest employees and seasoned industry associates. Many of technologies are placed in a wholly owned subsidiary of Quest, benefitting from the broader expertise of the company’s leadership.

Management

Quest’s management team delivers a wealth of experience in strategic business management, intellectual property, finance and marketing. The company’s internal resources, in tandem with its external network of financial, legal and managerial professionals, can develop creative solutions to the myriad of challenges involved in monetizing IP. Quest’s structured diligence and deployment procedures mitigate risks, maximize returns and deliver value to IP owners and shareholders alike.

Quest CEO and President Jon Scahill was the founder and managing director of the Urban-Rigney Group, LLC, a private consultancy specializing in new business/new venture development, operations optimization, and strategic analysis. Prior to launching his consultancy business, Mr. Scahill held numerous positions in sales and marketing, technical management, and product development in the consumer products/flexible packaging arena. Mr. Scahill holds a B.S. in chemical engineering from the University of Rochester, an MBA from Rochester’s Simon Graduate School of Business, and a JD from Pace University Law School. He is a registered patent attorney admitted to practice in New York, Florida, the District of Columbia and before the United States Patent and Trademark Office.

Quest Chief Technology Officer Timothy Scahill recently completed a merger and buyout of Managed Services Team LLC, an IT Managed Services provider. Prior to Managed Services Team, he was president of Layer 8 Group Inc., which merged with Structured Technologies Inc. to form Managed Services Team LLC. In his roles he was responsible for business strategy, acquisition, execution, as well as financial management. Mr. Scahill’s entrepreneurial acumen and proven record of successful management with sole discretionary responsibility, demonstrate the scope of his capability and his value to delivering results. He successfully completed his term on the boards of the Upstate New York Technology Council and Pariemus Rochester. Mr. Scahill completed a six-year term as secretary, executive council and a seat on the board of directors for Habitat for Humanity. He has served as president of the Western New York chapter of The Entrepreneurs Organization and continues to serve on the board as accelerator chair. Mr. Scahill is currently performing Cyber Intelligence, Security and Information Assurance work for an undisclosed organization.

Peter LaFauci is president of CFO Solutions, a Rochester, NY-based consulting firm offering knowledge-based financial and accounting solutions for emerging to medium-size companies. Mr. LaFauci is a seasoned executive with over 25 years of proven success in developing, leading and executing strategy in both publicly and privately held companies within the advertising, software development, internet, manufacturing and emerging technologies sectors. Peter possesses strong research and analytical skills as well as interpreting, summarizing and communicating financial and business information to others. Mr. LaFauci is a graduate of Saint Bonaventure University.

Quest Patent Research Corp. (OTCQB: QPRC), closed Wednesday's trading session at $0.013785, up 2.1111%, on 97,441 volume with 4 trades. The average volume for the last 3 months is 257,662 and the stock's 52-week low/high is $0.0013/$0.039999999.

Recent News

chart

Grapefruit Boulevard Investments Inc. (IGNG)

The QualityStocks Daily Newsletter would like to spotlight Grapefruit Boulevard Investments Inc., the wholly owned subsidiary of Imaging3 Inc. (IGNG).

Grapefruit Boulevard Investments, Inc. a Los Angeles based cannabis and CBD company and wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG). (collectively “Grapefruit” or the “Company”) which has been licensed by the State of California to both manufacture and distribute cannabis products in California since January 2018 is announcing today that on August 16, 2019 Justin Costello, CEO of GRN Funds in Seattle, WA, accepted appointment as Grapefruit’s initial non-director corporate advisor and the foundation member of its strategic advisory board.

Grapefruit Boulevard Investments Inc., a California corporation (“Grapefruit”), as of May 31, 2019, is a wholly owned subsidiary of Imaging3 Inc. (OTC: IGNG), a Delaware corporation whose shares of $.001 par value common stock are publicly traded on the OTCMarkets OTCQB Market under the symbol “IGNG.” IGNG is subject to the reporting requirements of the Securities Exchange Act of 1934 and files annual and quarterly reports pursuant thereto. Grapefruit holds licenses originally issued by the State of California in January 2018 to both manufacture and distribute cannabis products. Grapefruit’s management now owns a controlling interest in IGNG which now owns 100% of Grapefruit’s outstanding shares. As a result, IGNG’s financial reports will consolidate both IGNG’s and Grapefruit’s balance sheet, statement of operation and statement of cash flows and IGNG and Grapefruit will be operated as a single company. IGNG intends to change its name to Grapefruit and to obtain a more appropriate trading symbol as soon as possible. Hereinafter the combined companies will be referred to as “Grapefruit” or the “Company.”

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds licenses to both manufacture and distribute cannabis products which were originally issued in January 2018 and is fully compliant with all applicable laws and regulations to operate its cannabis manufacturing and distribution businesses.

The company is well-focused on sourcing only the “best of the best” raw cannabis materials to create the highest quality, most-trusted and consistent recreational and medical cannabis products for its customers. Grapefruit is committed to ensuring class-leading quality by rigorously testing the purity and potency of its raw materials throughout the manufacturing process and distribution chain.

Grapefruit owns and operates its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. The company’s extraction lab produces high quality, cannabis-derived distillate, also known as “honey oil,” from cannabis flower and “trim.” THC honey oil is one of base cannabis commodities which serves as the active ingredient in everything from infused edibles and tinctures/creams to the cartridges used in vapes and e-cigarettes. Honey oil often sells on the wholesale marketplace for thousands of dollars per liter, with pricing being dependent on quantity purchased, as well as other market factors such as the availability and cost of the underlying flowers and/or trim.

Grapefruit began its extraction operations in May 2019. Plans are in place to expand its honey oil production through the purchase of additional distillation equipment, which is expected to significantly increase the company’s production capacity by the fourth quarter of 2019. Grapefruit’s extraction lab is fully scalable and expansion will be built-out on a two-acre lot owned by Grapefruit at the Coachillin’ site adjacent to its current manufacturing and distribution operation.

Grapefruit selected the City of Desert Hot Springs for its cannabis extraction laboratory, because the city has created a friendly business environment for cannabis-based manufacturers, including incentives like the absence of taxes on cannabis oil production revenues. This affords Grapefruit a fundamental competitive market advantage over other Honey Oil producers.

The California cannabis regulatory scheme is unique in that it requires all cultivators (cannabis farms) and manufacturers (whether producing oils/distillates, infused edibles, tinctures creams or other cannabis products) to sell their products into the legal cannabis wholesale and retail markets exclusively through licensed distributors such as Grapefruit. Grapefruit initially obtained its California recreational and medicinal cannabis distribution license Jan. 4, 2018. In May 2019, Grapefruit was granted its provisional distribution license which is renewable annually, thereby cementing the regulatory foundation necessary to rapidly expand its distribution business.

Grapefruit’s distribution license affords it a twofold strategic advantage: first, to market and sell its own cannabis product lines to retailers throughout California; and second, to buy and resell bulk cannabis flowers and trim as well as all other legal cannabis products to properly licensed distributors and/or retailers throughout California.

The Coachillin’ Canna-Business Park, home to Grapefruit’s current operating facilities and adjacent two-acre parcel of land, is a 160-acre, self-contained legally mapped compound providing the Company with a fully permitted and serviced physical plant from which Grapefruit intends to establish a leading position in the booming California cannabis sector. The parcel was purchased by the Company prior to the Park’s full development, and the value of the land the Company owns has conservatively since doubled in value to over $2 million. Additional long-term benefits of the Coachillin’ compound include agricultural rates for power, which are currently $0.09 per kilowatt hour; the Park’s deep-water well that fully satisfies its need for water; and security expenses shared by all resident businesses. The Coachillin’ Park’s promoters also plan to position the Park, located only 10 miles north of rapidly growing uptown Palm Springs and less than 15 miles from the site of the Coachella and Stagecoach music festivals as a must-see canna-tourism destination.

Grapefruit’s ultimate goal is to become a vertically integrated, seed-to-sale cannabis and CBD product company serving the California market. Moreover, it plans to roll-out its product lines in other states, such as Nevada, Illinois, Oregon, Colorado and Washington. Grapefruit has plans to build a large, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy, a large extraction laboratory designed to extract both THC and CBD cannabinoids via non-volatile (ethanol) and volatile (butane) processes, a manufacturing space to produce Grapefruit’s vape lines and CBD products, an FDA-certified kitchen for the production of Grapefruit edibles and a distribution facility to sell all products into the entire cannabis market. The indoor grow canopy operation will be outfitted and operated to produce ultra-high-quality flowers and buds, some of which, along with the high-quality trim resulting from cleaning and maintaining the grow, will provide biomass necessary to feed the company’s extraction laboratory. Fueled by this hand cultivated biomass, Grapefruit’s lab will continuously produce pesticide and heavy metal-free world class honey oil to both serve as the active ingredient in all of Grapefruit’s branded and unbranded products and meet the projected ever-growing demand for high quality honey oil in the California market.

Grapefruit’s motto – A High You Can Trust – embodies its philosophy and ethos, reminding consumers of the company’s commitment to manufacturing, procuring and distributing only the highest quality all-natural cannabis flower, concentrates and related products that are free from pesticides, heavy metals and bacteria. Grapefruit will target its products to all recreational cannabis enthusiasts’ as continuous, consistent cannabis products. By relentlessly adhering to these policies Grapefruit intends to become the Titleist of the Cannabis industry, known for unwavering quality and consistency.

Grapefruit is managed by a team of experts possessing the experience, skill and resources required to succeed in the competitive cannabis marketplace. Founded by brothers Bradley Yourist, CEO, and Daniel Yourist, COO, Grapefruit has expanded to become a group of industry professionals sharing a passion for all things cannabis. Both the CEO & COO are attorneys licensed to practice law the State of California who possess expert cannabis licensing and regulatory expertise and experience, which will allow Grapefruit to deftly navigate the ever changing California regulatory landscape and apply for new cannabis licenses at reduced costs when necessary, rather than having to acquire licenses that are often overvalued and/or pay outside counsel to handle such matters.

Grapefruit also has its own line of cannabis-infused concentrates and edibles. Among the brands now in stores or soon to be launched are:

  • Rainbow Dreams is a new lifestyle brand designed specifically for the recreational cannabis marketplace. The Rainbow Dreams brand captures the anything goes party vibe of the 1970s by offering an array of cannabis products, such as a line of vape carts with unique cannabis strains combined with all-natural flavors for a superior no-burn experience. Rainbow Dreams fills an important niche in the marketplace as a top shelf quality product line that is competitively priced.
  • Sugar Stoned, which Grapefruit acquired in the winter of 2018, has always been a popular cannabis edibles brand which terminated operations when recreational cannabis became legal and required a license in California. Grapefruit purchased the Sugar Stoned brand in 2019 and it is now a Grapefruit portfolio brand consisting of a premium quality cannabis-infused gummy line with eight different flavors: blue raspberry, cherry, grape, peach, pineapple, sour apple, strawberry and watermelon. Grapefruit intends to expand the brand in the near future through the release of a variety of infused cookies.

Grapefruit Boulevard Investments Inc. (IGNG), closed Wednesday's trading session at $0.239, up 50.3145%, on 3,784,246 volume with 834 trades. The average volume for the last 3 months is 178,607 and the stock's 52-week low/high is $0.006095/$0.358999997.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

In the wake of The Bank of Montreal’s (BMO) completion of a block trade of Aurora Cannabis (TSX: ACB) (NYSE: ACB) held shares of The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), leadership is reportedly pleased to see that 28.8 million overhanging shares remaining from that transaction have been successfully placed, predominately with institutional asset managers.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Wednesday's trading session at $2.065, up 4.8649%, on 877,242 volume with 1,005 trades. The average volume for the last 3 months is 594,665 and the stock's 52-week low/high is $1.60699999/$7.89379978.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions (OTCQB: SGSI), a leading single-source provider of next-generation communications network infrastructure and maintenance solutions, announced that it obtained $3.7 million in new contracts during the second quarter of 2019 (http://nnw.fm/LCk8G). To view the full article, visit: http://nnw.fm/8OANf.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Wednesday's trading session at $0.035, up 6.8376%, on 64,035 volume with 9 trades. The average volume for the last 3 months is 205,030 and the stock's 52-week low/high is $0.014999999/$2.5999999.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, announced that independent researchers reported in a recent study that TUSC2, a tumor suppressor gene and the active agent in Genprex’s Oncoprex™ immunogene therapy, prevented tumor growth in triple-negative breast cancer (TNBC), which is currently considered an incurable cancer with limited therapeutic options. Genprex has no affiliation with these researchers.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Wednesday's trading session at $0.8899, up 0.838527%, on 721,933 volume with 1,983 trades. The average volume for the last 3 months is 39,889 and the stock's 52-week low/high is $0.640999972/$2.55999994.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile Inc. (TSX-V:SIM / OTCQX:SYATF) is pleased to announce that it has received an additional purchase order from its first US customer to equip their fleet of yellow school buses with its Uniden® UV350, bringing the total order to over $1MM.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Wednesday's trading session at $0.3523, up 0.772311%, on 156,700 volume with 17 trades. The average volume for the last 3 months is 47,364 and the stock's 52-week low/high is $0.288599997/$0.446249991.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

CannabisNewsWire Editorial Coverage: Hemp may be taking the first steps to overtake tobacco as a leading industry in Kentucky. Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) is among the companies moving into Kentucky, with a million-dollar investment in hemp growth.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Wednesday's trading session at $0.0155, up 28.0992%, on 14,160,003 volume with 342 trades. The average volume for the last 3 months is 4,137,132 and the stock's 52-week low/high is $0.00975/$0.164000004.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) (the “Company” or “PLUS”), a leading cannabis branded products company in California, today announced that it has entered into an agreement with a certain arm’s length party with respect to the settlement of USD$1,044,806.03 owing or to be owing to such creditor by the Company for services rendered.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Wednesday's trading session at $3.3975, up 1.1161%, on 18,369 volume with 38 trades. The average volume for the last 3 months is 36,800 and the stock's 52-week low/high is $2.51999998/$6.00810003.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Geyser Brands (TSX.V: GYSR) has developed its proprietary NanoFusion advanced delivery-system technology using natural materials to improve the transportation and delivery of active ingredients. Geyser’s NanoFusion is currently the only natural nanoemulsion on the market featuring no solvents or inflammatory agents. To view the full article, visit: http://nnw.fm/xYs2i.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed Wednesday's trading session at $0.41, even for the day, on 17,500 volume. The average volume for the last 3 months is 3,197 and the stock's 52-week low/high is $0.409999996/$0.850000023.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

CannabisNewsWire Editorial Coverage: A desire to move away from smoking may be fueling growth in the edible cannabis products. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has created a bold new technology to make cannabis’ active ingredients more palatable and absorbable.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Wednesday's trading session at $0.69, even for the day, on 79,585 volume with 73 trades. The average volume for the last 3 months is 73,982 and the stock's 52-week low/high is $0.600000023/$2.20000004.

Recent News

chart

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

OrganiGram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) was highlighted in a publication from Financialnewsmedia.com, examining how recent advances in marijuana technology have changed the industry. From cultivation to consumption, technology is improving the end product and using new farming techniques to produce better strains.

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Wednesday's trading session at $4.73, off by 0.421053%, on 623,808 volume with 2,484 trades. The average volume for the last 3 months is 1,031,978 and the stock's 52-week low/high is $2.97000002/$8.43999958.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to announce the formation of its Strategic Advisory Board, a group of respected business leaders that will provide guidance to Canopy Rivers' executive team as it continues to build and strengthen the Company's global portfolio of leading cannabis companies.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Wednesday's trading session at $1.86, off by 2.7095%, on 33,890 volume with 91 trades. The average volume for the last 3 months is 108,089 and the stock's 52-week low/high is $1.60000002/$7.30155992.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) is working to improve global well-being with cannabis. Since 2014, the company has been at the center of the cannabis space with a mission of cultivating the globe’s best product and emerging as a leader in this worldwide industry. Headquartered in Toronto, Ontario, Supreme Cannabis Company uses its knowledge of the plant to create transformative businesses, products and brands that deliver positive experiences. Also today, the company was highlighted in a publication from CFN Media, examining how consumers don't mind digging into their wallets for better quality and an improved experience. This trend is becoming evident in the burgeoning legal cannabis industry as well and Supreme Cannabis is ahead of it, including launching a new high-end cannabis sativa cultivar this week, branded "Jack Haze," through its subsidiary 7ACRES. Additionally, the company was highlighted in a publication from Financialnewsmedia.com, examining how recent advances in marijuana technology have changed the industry.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Wednesday's trading session at $1.075, off by 1.3761%, on 253,494 volume with 324 trades. The average volume for the last 3 months is 391,167 and the stock's 52-week low/high is $0.850000023/$2.03999996.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) and Convectium (OTCQB: JKSM )featured in CFN Media. Convectium is the inventor of the world’s first cannabis oil filling system and proprietary packaging systems. This is a major advancement at a time when about 80% of all concentrate products (vapes and pods) are filled manually. By hand, oil cartridge fills are completed at a paltry 75 per hour. Convectium’s 710 Shark system can exceed that in less than a minute on its way to produce between 6,000-12,000 in an hour. Also today, the company was highlighted in today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Wednesday's trading session at $0.0123, off by 1.60%, on 2,912,463 volume with 92 trades. The average volume for the last 3 months is 5,392,392 and the stock's 52-week low/high is $0.009999999/$0.041000001.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.